Trials / Recruiting
RecruitingNCT06543823
ST250 as a Therapeutic Option for Head & Neck Reconstruction
The Use of Suprathel®250 as a Novel Therapeutical Option for Mucosal Healing in Head and Neck Surgery
- Status
- Recruiting
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Alaa Emara · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
To assess the use of SupraThel 250 for mucosal reconstruction in the Head \& Neck region. The membrane will be applied after tonsillectomy procedures and compared to bare wounds' healing
Detailed description
After tonsillectomy procedures, the wound is usually left bare to heal. This causes severe pain postoperatively and postoperative hemorrhage. SupraTHEL 250 is a synthetic biodegradable PLA membrane which is proven as a skin membrane in burn wounds with excellent result. We therefore hypothesize that the use opf SupraTHEL 250 after tonsillectomy procedures will allow for faster , less painful healing of the wound bed which allows for a better quality of life for the patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | SupraTHEL 250 | the membrane is placed onto the wound bed and fixed in place by resorbable interrupted sutures |
| OTHER | Comparator | no membrane is placed onto the wound bed , left bare to heal |
Timeline
- Start date
- 2025-04-30
- Primary completion
- 2025-12-01
- Completion
- 2026-02-01
- First posted
- 2024-08-09
- Last updated
- 2025-05-18
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT06543823. Inclusion in this directory is not an endorsement.